Evidence map›Paper›PMID 34388204›Full record

ArticlePloS one2021

Identification and functional modelling of plausibly causative cis-regulatory variants in a highly-selected cohort with X-linked intellectual disability.

Hemant Bengani, Detelina Grozeva, Lambert Moyon, Shipra Bhatia, Susana R Louros, Jilly Hope, Adam Jackson, James G Prendergast, Liusaidh J Owen, Magali Naville and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 2 countries.

Hemant BenganiMRC Human Genetics Unit, IGMM, University of Edinburgh (UoE), Edinburgh, United Kingdom.
Detelina GrozevaCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-3239-8415
Lambert MoyonEcole Normale Supérieure, Institut de Biologie de l'ENS, IBENS, Paris, France.ORCID 0000-0003-2390-3942
Shipra BhatiaMRC Human Genetics Unit, IGMM, University of Edinburgh (UoE), Edinburgh, United Kingdom.ORCID 0000-0002-2091-7858
Susana R LourosCentre for Discovery Brain Sciences, Patrick Wild Centre, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-1012-0386
Jilly HopeInstitute of Genomic and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Adam JacksonCentre for Discovery Brain Sciences, Patrick Wild Centre, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-3554-6682
James G PrendergastRoslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-8916-018X
Liusaidh J OwenMRC Human Genetics Unit, IGMM, University of Edinburgh (UoE), Edinburgh, United Kingdom.ORCID 0000-0003-0363-1775
Magali NavilleEcole Normale Supérieure, Institut de Biologie de l'ENS, IBENS, Paris, France.ORCID 0000-0002-6821-2427
Jacqueline RaingerMRC Human Genetics Unit, IGMM, University of Edinburgh (UoE), Edinburgh, United Kingdom.
Graeme GrimesInstitute of Genomic and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-3106-5996
Mihail HalachevInstitute of Genomic and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-4594-4588
Laura C MurphyInstitute of Genomic and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-0029-0434
Olivera Spasic-BoskovicEast Midlands and East of England NHS Genomic Laboratory Hub, Molecular Genetics, Adden brooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-1583-8132
Veronica van HeyningenMRC Human Genetics Unit, IGMM, University of Edinburgh (UoE), Edinburgh, United Kingdom.ORCID 0000-0003-0359-0141
Peter KindCentre for Discovery Brain Sciences, Patrick Wild Centre, University of Edinburgh, Edinburgh, United Kingdom.
Catherine M AbbottSimons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-8794-7173
Emily OsterweilCentre for Discovery Brain Sciences, Patrick Wild Centre, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-0582-2284
F Lucy RaymondCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Hugues Roest CrolliusEcole Normale Supérieure, Institut de Biologie de l'ENS, IBENS, Paris, France.
David R FitzPatrickMRC Human Genetics Unit, IGMM, University of Edinburgh (UoE), Edinburgh, United Kingdom.ORCID 0000-0003-4861-969X
University of Edinburgh · GBInstitute of Genetics and Cancer · GBÉcole Normale Supérieure - PSL · FRUniversity of Cambridge · GBCambridge University Hospitals NHS Foundation Trust · GBRoslin Institute · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council MC_UU_00007/3Medical Research Council MR/M006336/1
6 · The paper itself

Abstract

Identifying causative variants in cis-regulatory elements (CRE) in neurodevelopmental disorders has proven challenging. We have used in vivo functional analyses to categorize rigorously filtered CRE variants in a clinical cohort that is plausibly enriched for causative CRE mutations: 48 unrelated males with a family history consistent with X-linked intellectual disability (XLID) in whom no detectable cause could be identified in the coding regions of the X chromosome (chrX). Targeted sequencing of all chrX CRE identified six rare variants in five affected individuals that altered conserved bases in CRE targeting known XLID genes and segregated appropriately in families. Two of these variants, FMR1CRE and TENM1CRE, showed consistent site- and stage-specific differences of enhancer function in the developing zebrafish brain using dual-color fluorescent reporter assay. Mouse models were created for both variants. In male mice Fmr1CRE induced alterations in neurodevelopmental Fmr1 expression, olfactory behavior and neurophysiological indicators of FMRP function. The absence of another likely causative variant on whole genome sequencing further supported FMR1CRE as the likely basis of the XLID in this family. Tenm1CRE mice showed no phenotypic anomalies. Following the release of gnomAD 2.1, reanalysis showed that TENM1CRE exceeded the maximum plausible population frequency of a XLID causative allele. Assigning causative status to any ultra-rare CRE variant remains problematic and requires disease-relevant in vivo functional data from multiple sources. The sequential and bespoke nature of such analyses renders them time-consuming and challenging to scale for routine clinical use.

Indexed as

Genes, X-LinkedGenome, HumanRegulatory Elements, TranscriptionalAnimalsAnimals, Genetically ModifiedBrainChromosome MappingCohort StudiesDisease Models, AnimalEmbryo, NonmammalianExomeFragile X Messenger Ribonucleoprotein 1Gene FrequencyGenotypeHumansMaleFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Nerve Tissue ProteinsTenascinteneurin-1

Identifiers

PMID34388204
PMCPMC8362966
OpenAlexW3192525709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.